A detailed history of Hexagon Capital Partners LLC transactions in Sanofi stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 5,356 shares of SNY stock, worth $285,314. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,356
Previous 5,101 5.0%
Holding current value
$285,314
Previous $247,000 24.7%
% of portfolio
0.06%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$48.54 - $58.53 $12,377 - $14,925
255 Added 5.0%
5,356 $308,000
Q2 2024

Jul 12, 2024

BUY
$45.39 - $50.36 $12,119 - $13,446
267 Added 5.52%
5,101 $247,000
Q1 2024

Apr 18, 2024

SELL
$45.75 - $52.48 $7,274 - $8,344
-159 Reduced 3.18%
4,834 $234,000
Q4 2023

Feb 05, 2024

BUY
$43.13 - $54.79 $42,439 - $53,913
984 Added 24.54%
4,993 $248,000
Q3 2023

Oct 23, 2023

BUY
$50.95 - $55.2 $25,220 - $27,324
495 Added 14.09%
4,009 $215,000
Q2 2023

Jul 24, 2023

BUY
$50.45 - $57.18 $33,902 - $38,424
672 Added 23.65%
3,514 $189,000
Q1 2023

Apr 24, 2023

SELL
$45.86 - $54.45 $22,058 - $26,190
-481 Reduced 14.47%
2,842 $154,000
Q4 2022

Jan 13, 2023

SELL
$38.86 - $48.55 $5,712 - $7,136
-147 Reduced 4.24%
3,323 $0
Q3 2022

Oct 17, 2022

BUY
$37.22 - $100.5 $45,147 - $121,906
1,213 Added 53.74%
3,470 $132,000
Q2 2022

Jul 21, 2022

BUY
$48.99 - $57.46 $37,575 - $44,071
767 Added 51.48%
2,257 $113,000
Q3 2021

Nov 12, 2021

SELL
$47.89 - $53.12 $957 - $1,062
-20 Reduced 1.32%
1,490 $72,000
Q1 2021

May 13, 2021

BUY
$45.46 - $50.51 $1,772 - $1,969
39 Added 2.65%
1,510 $74,000
Q4 2020

Feb 05, 2021

SELL
$45.3 - $51.62 $43,035 - $49,039
-950 Reduced 39.24%
1,471 $71,000
Q3 2020

Nov 10, 2020

BUY
$49.47 - $53.77 $119,766 - $130,177
2,421 New
2,421 $112,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $134B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.